Golimumab for the Treatment of Refractory Behcet's Uveitis
Clinical trial NCT04218565 · TERMINATED
Trial details
- NCT number
- NCT04218565
- Sponsor
- Wenjie Zheng
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-15
- Primary completion
- 2022-12-15
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.